FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmacology and deals with method of obtaining microspheres from biodegradable polymer, including: addition of organic solvent to polymer, obtaining polymer solution (stage 1); dispersion of glucose level-regulating peptide in stage 1 polymer solution, obtaining medication dispersion and mixing alcohol or mixture of alcohol and organic acid with medication dispersion, obtaining solution with dispersed in it medication (stage 2); and obtaining microsphere from solution with dispersed in it stage 2 medication (stage 3), where glucose level-regulating peptide represents exedin-4 and where biodegradable polymer is selected from group, consisting of poly-L-lactic acid, D-lactic acid and glycolic acid copolymer, L-lactic acid and glycolic acid copolymer and D,L-lactic acid and glycolic acid copolymer.
EFFECT: invention ensures obtaining microsheres which demonstrate neither initial burst effect nor incomplete release, ensure release of medications of zero order and high efficiency of incapsulation and high stability.
13 cl, 15 ex, 7 tbl, 5 dwg
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | COMPOSITION AND MICROSPHERE WITH CONTROLLED EXENDIN RELEASE AND METHOD OF OBTAINING MICROSPHERE | 2008 | 
										Li Khi-EnSol Yn-EnKim Chun-SikBehk Mi-ChinKim Chzhon-SuLi Chzhu-KhanChkheh En-ChinLim Chkheh-ChinBehk Mi-EnChkhve Kho-Il' | RU2463040C2 | 
							
              
                | DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2005 | 
										Jukhua LiChien Bendzhamin | RU2390355C2 | 
							
              
                | METHOD FOR MAKING SLOW-RELEASE MICROSPHERES WITH IMPROVED DISPERSIBILITY AND SYRINGE NEEDLE PERMEABILITY | 2007 | 
										Li Khee-JongKim Dzung-SooShin Eun-KhoKim Seong-KiuSeol Eun-JoungBaek Mi-DzinBaek Mi-JoungChae Jeon-DzinChoi Kho-Il | RU2403017C2 | 
							
              
                | PHARMACEUTICAL COMPOSITION CONTAINING PROLONGED RELEASE MICROSPHERES CONTAINING GPP-1 ANALOGUE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2021 | 
										Na, YonghaWon, DongpilKim, YejinLee, JuhanChoe, HeekyoungSeol, EunyoungLee, Heeyong | RU2834992C1 | 
							
              
                | HIGH STABILITY PHARMACEUTICAL COMPOSITIONS | 2007 | 
										Li JukhuaChien Bendzhamin | RU2427383C2 | 
							
              
                | MICROPARTICLE AND PHARMACEUTICAL COMPOSITION THEREOF | 2009 | 
										Kakizava JosinoriNisio RejdziMitizoe DzundziKojva MasakazuIda NobuoKhirano TajsukeKosi Joitiro | RU2490009C2 | 
							
              
                | SUSTAINED-RELEASE COMPOSITION AND METHOD FOR ITS PREPARING | 2002 | 
										Jamamoto KazumitiJamada AkikoKhata Esio | RU2301661C2 | 
							
              
                | METHODS FOR DELIVERY OF NEUROPROTECTIVE POLYPEPTIDE TO CENTRAL NERVOUS SYSTEM | 2017 | 
										Kim, Dong, SeokKim, Hee, KyungGreig, Nigel, H. | RU2790566C2 | 
							
              
                | EMULSION FOR MICROENCAPSULATION CONTAINING BIODEGRADABLE SURFACTANT BLOCK COPOLYMERS AS STABILIZERS | 2011 |  | RU2617057C2 | 
							
              
                | PHARMACEUTICAL COMPOSITIONS WITH A SELECTED DURATION OF RELEASE | 2017 | 
										Li, YukhuaGuarino, Endryu | RU2756514C1 |